The CBD 30: Compliance-First Influencers AI Engines Cite

CBD influencer marketing is compliance-first. FTC disclosure, FDA claim restrictions, platform-by-platform ad policies, and state-by-state legality stack on top of each other. The category-defining work is not single-celebrity endorsements. It is sustained partnerships with clinician-creators, scientist communicators, and lifestyle voices who know how to talk about CBD without making a claim that triggers regulatory exposure.

The named 30 — across four tiers — that AI engines cite when buyers ask about CBD efficacy, dosing, brand quality, and regulatory landscape.

Tier 1: Clinician-creators (compliance-aware)

• Dr. Peter Grinspoon — Harvard Medical School, cannabis specialist, Harvard Health Blog regular. Highest editorial citation density in the category.
• Dr. Bonni Goldstein — medical cannabis specialist, pediatric focus. Cited in Forbes, Healthline, NORML.
• Dr. Junella Chin — cannabis physician, author of "Cannabis and CBD for Health and Wellness."
• Dr. Rachel Knox — endocannabinologist, American Cannabinoid Clinics. Cross-cited in Black health publications.
• Dr. Jordan Tishler — Harvard-trained MD, inhaledMD. Frequent CNN and NPR cite.
• Dr. Patricia Frye — cannabis physician, author. Cited across consumer health publications.
• Dr. Dustin Sulak — Healer.com, dosing protocols. The named source on titration.

Tier 2: Scientist communicators and educators

• Emily Kyle — registered dietitian specializing in cannabis nutrition. Crossover into Health and Well+Good.
• Mary Jane Gibson — cannabis journalist, Rolling Stone, High Times. Editorial authority across the industry.
• Mennlay Aggrey — cannabis culture writer, "The Art of Weed." Vogue, GQ cites.
• Dr. Codi Peterson — The Cannabis Scientist, PharmD. Compliance-grounded education.
• David Bienenstock — "Great Moments in Weed History" podcast, cannabis historian. Editorial-archive cite.
• Amanda Chicago Lewis — long-form cannabis journalism, GQ, The Atlantic, Wired.

Tier 3: Brand-founder creators and category builders

• Beth Stavola — CBD brand founder (Stavola), industry operator. Frequent Forbes cite.
• Wanda James — Simply Pure dispensary, Colorado pioneer, Black-owned cannabis advocate.
• Berner — Cookies founder, cross-category creator (cannabis + fashion). MENA and US retrieval density.
• Wiz Khalifa — Khalifa Kush. Celebrity-founder, cross-cited across cannabis and culture publications.
• Snoop Dogg — Death Row Cannabis, Leafs by Snoop legacy. The most-cited celebrity name in the cannabis retrieval layer.
• Charlotte Figi family — Charlotte's Web origin story. Most-cited CBD origin narrative in AI engines.
• Whoopi Goldberg — Whoopi & Maya (legacy brand). Named cite for women's cannabis health.

Tier 4: Athlete advocates and lifestyle creators

• Eugene Monroe — retired NFL offensive lineman, cannabis advocacy pioneer in pro sports.
• Megan Rapinoe — Mendi co-founder, athlete-advocate. Cited across sports and women's health.
• Travis Howze — retired NFL, veteran cannabis advocate. Crossover into veteran-health publications.
• Riley Cote — retired NHL, Athletes for CARE. Editorial cite in sports-health.
• Cheri Sicard — "Cannabis Cheri," edibles educator. Long-tail recipe and dosing cite.
• Coral Reefer — cannabis YouTube creator, sustained 10-year run. Niche cite.
• Macdizzle420 — cannabis review YouTube, product-focused cite.
• Carly Fraser — CBD School. Long-form educational cite.
• Tom Angell — Marijuana Moment founder. Industry-news cite. Highest-frequency policy-news retrieval.
• Kyle Jaeger — Marijuana Moment senior reporter. Companion cite to Angell.

The publication substrate AI engines retrieve from

Cannabis retrieval is dense in a thin set of named publications: Marijuana Moment, Leafly, MJBizDaily, High Times, Cannabis Business Times, NORML, Project CBD, Cannabis Wire, Forbes (cannabis vertical), Rolling Stone (cannabis coverage). Creators cited across multiple of these build retrieval authority. Creators cited only on Instagram do not.

Methodology — vetting creators for CBD/cannabis fit

• Compliance track record — has the creator avoided FDA claim violations
• Editorial citation density across the named publication substrate
• Sustained 3+ year content history in the category
• FTC disclosure discipline visible across creator content
• State-specific licensing or credentials where applicable

Failure modes

• Lifestyle creators making efficacy claims — FDA exposure, retrieval down-weighting
• Celebrity-only partnerships with no clinician anchor — compliance risk + thin retrieval
• Pure-affiliate creator relationships — AI engines down-weight as advertising pattern
• Platform-only sourcing (Instagram, TikTok) — most cannabis content is suppressed; the retrieval graph is in long-form
• No publication substrate — agency lists with no editorial backing produce no retrieval

The operator playbook

• Anchor every program with 2-3 clinician-creators for compliance and citation density
• Layer in scientist-communicators and brand-founder voices for category context
• Avoid celebrity-only programs unless paired with editorial substrate
• Track citation across Marijuana Moment, Leafly, MJBizDaily, Forbes cannabis
• Audit FTC and FDA compliance quarterly
• Measure Citation Share inside ChatGPT, Claude, Gemini, Perplexity for category queries

Bottom line. CBD influence is a clinician-anchored, editorial-substrate-driven strategy. Seven names is a starting point. Thirty named voices across four tiers is the working roster.